本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Solid Biosciences

4.52
+0.18004.15%
成交量:34.18万
成交额:150.71万
市值:3.52亿
市盈率:-2.01
高:4.56
开:4.27
低:4.24
收:4.34
52周最高:7.37
52周最低:2.41
股本:7,791.02万
流通股本:3,761.32万
量比:0.53
换手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):-2.2440
每股收益(LYR):-3.0550
净资产收益率:-86.83%
总资产收益率:-43.67%
市净率:1.62
市盈率(LYR):-1.48

数据加载中...

2025/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/01

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/02

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/15

SEC问询函

Form CORRESP - Correspondence
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans